Resolve Biosciences
Resolve Biosciences is creating solutions which offer the power of Molecular Cartography enabling scientists to gain valuable insights at subcellular resolution, across vast numbers of biomolecules (RNA, DNA, proteins) to create three-dimensional maps of molecular activity in living cells.
Press releases
Press
Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography™ Workflow
Funding led by Patient Square Capital follows successful launch of groundbreaking system that delivers highest-resolution view of subcellular, single-molecule, spatial biology
MONHEIM AM RHEIN, Germany – October 24, 2022 – Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS C
Press
Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular Cartography™ platform
Resolve Biosciences, the pioneer in Molecular Cartography™, announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer.
The company’s Molecular Cartography platform is a groundbreaking multi-analyte and highly multiplex spati
Info & Contact
Address
Creative Campus
40789 Monheim a. Rhein
40789 Monheim a. Rhein
In portfolio
27. Nov 2020